Status:
TERMINATED
Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?
Lead Sponsor:
Columbia University
Conditions:
Graves Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this research is to find out if SSKI (Potassium Iodide) reduces vascularity (the number and concentration of blood vessels) and improves how well patients do after surgery for removal o...
Detailed Description
Patients with Graves' disease and goiters tend to have very vascular thyroid glands, which increases operative bleeding risks/rates. Many surgeons treat these patients with preoperative SSKI which is ...
Eligibility Criteria
Inclusion
- individuals diagnosed with Graves' disease undergoing total thyroidectomy for cure of disease.
Exclusion
- no Graves' disease
- \< 18 years old
Key Trial Info
Start Date :
February 10 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 3 2023
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04080505
Start Date
February 10 2015
End Date
March 3 2023
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032